Literature DB >> 26202122

Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road?

David van Duin1, Yohei Doi2.   

Abstract

Carbapenem-resistant Klebsiella pneumoniae strains that produce K. pneumoniae carbapenemase (KPC) have spread globally in the last decade. Colistin is a key agent in treating infections caused by this pathogen. In this issue of the Journal of Clinical Microbiology, Giani et al. (T. Giani, F. Arena, G. Vaggelli, V. Conte, A Chiarell, L. H. De Angelis, R. Fornaini, M. Grazzini, F. Niccolini, P. Pecile, and G. M. Rossolini, J Clin Microbiol 53:3341-3344, 2015, http://dx.doi.org/10.1128/JCM.01017-15) describe a sustained outbreak of colistin-resistant KPC-producing K. pneumoniae.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202122      PMCID: PMC4572557          DOI: 10.1128/JCM.01399-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Francesco Giuseppe De Rosa; Maddalena Giannella; Daniele Roberto Giacobbe; Matteo Bassetti; Angela Raffaella Losito; Michele Bartoletti; Valerio Del Bono; Silvia Corcione; Giuseppe Maiuro; Sara Tedeschi; Luigi Celani; Chiara Simona Cardellino; Teresa Spanu; Anna Marchese; Simone Ambretti; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2015-04-21       Impact factor: 5.790

2.  NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases.

Authors:  Anu Jain; Katie L Hopkins; Jane Turton; Michel Doumith; Robert Hill; Richard Loy; Daniele Meunier; Rachel Pike; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2014-04-25       Impact factor: 5.790

3.  Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

Authors:  Zubair A Qureshi; Lauren E Hittle; Jessica A O'Hara; Jesabel I Rivera; Alveena Syed; Ryan K Shields; Anthony W Pasculle; Robert K Ernst; Yohei Doi
Journal:  Clin Infect Dis       Date:  2015-01-28       Impact factor: 9.079

4.  Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.

Authors:  Roger L Nation; Jian Li; Otto Cars; William Couet; Michael N Dudley; Keith S Kaye; Johan W Mouton; David L Paterson; Vincent H Tam; Ursula Theuretzbacher; Brian T Tsuji; John D Turnidge
Journal:  Lancet Infect Dis       Date:  2014-10-21       Impact factor: 25.071

5.  Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant.

Authors:  Tommaso Giani; Fabio Arena; Guendalina Vaggelli; Viola Conte; Adriana Chiarelli; Lucia Henrici De Angelis; Rossella Fornaini; Maddalena Grazzini; Fabrizio Niccolini; Patrizia Pecile; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

6.  Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.

Authors:  Marisa L Winkler; Krisztina M Papp-Wallace; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2015-05-08       Impact factor: 5.790

Review 7.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

Review 8.  Treating infections caused by carbapenemase-producing Enterobacteriaceae.

Authors:  L S Tzouvelekis; A Markogiannakis; E Piperaki; M Souli; G L Daikos
Journal:  Clin Microbiol Infect       Date:  2014-07-12       Impact factor: 8.067

9.  The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.

Authors:  Laurent Poirel; Aurélie Jayol; Séverine Bontron; Maria-Virginia Villegas; Melda Ozdamar; Salih Türkoglu; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2014-09-03       Impact factor: 5.790

Review 10.  Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria.

Authors:  Laurent Dortet; Laurent Poirel; Patrice Nordmann
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

View more
  20 in total

Review 1.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

2.  Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.

Authors:  Elizabeth Temkin; Julian Torre-Cisneros; Bojana Beovic; Natividad Benito; Maddalena Giannella; Raúl Gilarranz; Cameron Jeremiah; Belén Loeches; Isabel Machuca; María José Jiménez-Martín; José Antonio Martínez; Marta Mora-Rillo; Enrique Navas; Michael Osthoff; Juan Carlos Pozo; Juan Carlos Ramos Ramos; Marina Rodriguez; Miguel Sánchez-García; Pierluigi Viale; Michel Wolff; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 3.  MCR: modern colistin resistance.

Authors:  I Caniaux; A van Belkum; G Zambardi; L Poirel; M F Gros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-21       Impact factor: 3.267

4.  Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital - a five-year retrospective study.

Authors:  Ana Gorgulho; Ana Maria Grilo; Manuel de Figueiredo; Joana Selada
Journal:  Germs       Date:  2020-06-02

5.  Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.

Authors:  Laura J Rojas; Madiha Salim; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Steve Marshall; Susan D Rudin; T Nicholas Domitrovic; Andrea M Hujer; Kristine M Hujer; Yohei Doi; Keith S Kaye; Scott Evans; Vance G Fowler; Robert A Bonomo; David van Duin
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

6.  Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.

Authors:  Stefan E Richter; Loren Miller; Daniel Z Uslan; Douglas Bell; Karol Watson; Romney Humphries; James A McKinnell
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 11.677

7.  Epidemiology and biomolecular characterization of carbapenem-resistant klebsiella pneumoniae in an Italian hospital.

Authors:  M L Cristina; M Sartini; G Ottria; E Schinca; N Cenderello; M P Crisalli; P Fabbri; G Lo Pinto; D Usiglio; A M Spagnolo
Journal:  J Prev Med Hyg       Date:  2016-09

8.  Occurrence and Genomic Characterization of ESBL-Producing, MCR-1-Harboring Escherichia coli in Farming Soil.

Authors:  Beiwen Zheng; Chen Huang; Hao Xu; Lihua Guo; Jing Zhang; Xin Wang; Xiawei Jiang; Xiao Yu; Linfeng Jin; Xuewen Li; Youjun Feng; Yonghong Xiao; Lanjuan Li
Journal:  Front Microbiol       Date:  2017-12-14       Impact factor: 5.640

Review 9.  Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries.

Authors:  Corrado Girmenia; Alessandra Serrao; Martina Canichella
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-07-01       Impact factor: 2.576

10.  Lipidomic Analysis of the Outer Membrane Vesicles from Paired Polymyxin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates.

Authors:  Raad Jasim; Mei-Ling Han; Yan Zhu; Xiaohan Hu; Maytham H Hussein; Yu-Wei Lin; Qi Tony Zhou; Charlie Yao Da Dong; Jian Li; Tony Velkov
Journal:  Int J Mol Sci       Date:  2018-08-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.